CLINICAL_TRIALS
ClinicalTrials.gov record update
The Efficacy of Selumetinib in Chinese Paediatric Participants With Post-operative Neurofibromatosis Type 1 (NF1)-Associated PNs: A PhaseⅡ, Multicenter, Randomised, Double-Blinded, Placebo-Controlled Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05825365
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:38.113432+00:00
- Published At
- 2023-08-14T00:00:00+00:00
- Record Updated At
- 2023-08-14
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Neurofibromatosis Type 1", "Plexiform Neurofibromas", "Post-operative"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-08-14"- protocolSection.identificationModule.nctId
"NCT05825365"- protocolSection.identificationModule.officialTitle
"The Efficacy of Selumetinib in Chinese Paediatric Participants With Post-operative Neurofibromatosis Type 1 (NF1)-Associated PNs: A Phase\u2161, Multicenter, Randomised, Double-Blinded, Placebo-Controlled Study"- protocolSection.statusModule.overallStatus
"WITHDRAWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.